Hey
Dmd explain
Duchenne muscular dystrophy pathophysiology clinical features 2025
"Duchenne muscular dystrophy"[MeSH Terms] AND treatment
| Test | Finding |
|---|---|
| Serum CK | 20-100x elevated (markedly raised due to leaking muscle) |
| Genetic testing | Positive in 90-95% of patients - confirms frameshift mutation |
| Muscle biopsy | Used if genetic testing is negative; shows fiber necrosis, inflammation, fibrosis, variation in fiber size |
| Immunohistochemistry | Absent dystrophin staining (except "revertant fibers") |
| Feature | DMD | BMD |
|---|---|---|
| Mutation | Frameshift - no dystrophin | In-frame - reduced/abnormal dystrophin |
| Onset | 2-5 years | Teens/adulthood |
| Ambulation loss | ~12-15 years | After 16 years (often later) |
| Severity | Severe | Milder |